课题基金 / 基金详情

Mechanisms via which the human fetus is at risk from over-the-counter analgesics

Mechanisms via which the human fetus is at risk from over-the-counter analgesics
人类胎儿面临非处方镇痛药风险的机制
批准号:
1942576
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
处方药的使用很普遍,64%的美国妇女在怀孕期间开了一种或多种药物(不包括维生素/矿物质)。此外,非处方药的使用非常普遍,特别是用于止痛(如扑热息痛、布洛芬)。这些药物的使用(包括剂量和频率)难以调节,并且在妊娠期间使用镇痛药与后代先天性缺陷风险增加之间存在关联。一个例子是,如果新生儿在子宫内暴露于扑热息痛,就会增加隐睾症和减少男性化。众所周知,与未怀孕妇女相比,怀孕期间药物的药代动力学发生了改变,而对胎儿人体代谢、生物转化和药物清除的了解非常有限。因此,在怀孕期间不适当地接触药物会对后代终生的健康和福祉产生严重的不利影响,例如母亲吸烟或大量饮酒就很容易理解这种模式。虽然我们和其他人已经证明胎儿肝脏在妊娠的前/中期是活跃的,但对药物及其代谢物的摄取、代谢/生物转化和清除所涉及的细胞机制知之甚少。因此,本博士的目的是确定肝脏机制,以调节或保护人类胎儿暴露于止痛剂(如扑热息痛)及其代谢物所带来的潜在风险。为了实现这一目标,该学生将成为Fowler协调的SAFeR研究(苏格兰高级胎儿研究)的一部分。本研究涉及在阿伯丁和格拉斯哥大学收集和研究选择性终止的正常人类胎儿(妊娠7至20周)(伦理批准:REC:15/NS/0123)。此外,我们(米切尔)已经在一些更安全的研究胎儿的血浆中测量到了高水平的扑热息痛,清楚地表明这种药物是从母亲进入胎儿体内的。目标1:该学生将对已经获得的80个胎儿肝脏的下一代测序(RNA-seq)和蛋白质组学数据进行数据挖掘,这是Fowler获得的MRC资助的一部分。这将揭示参与扑热息痛等药物代谢和清除的人类胎儿肝脏基因和蛋白质通路,以及胎儿性别是否存在差异。目的2:在爱丁堡,该学生将利用Hay的体外肝脏系统探索镇痛药及其代谢物对肝功能的影响,以了解镇痛药及其代谢物代谢过程中涉及的细胞内机制,并将其与胎儿进行比较。目的3:学生将利用前两个目的的数据来研究高水平和低水平扑热息痛胎儿的肝脏,以确定哪种肝脏机制为胎儿提供保护和增加风险的结果。本博士学位的预期影响是提供对常见非处方镇痛药对人类胎儿肝脏影响的基本机制理解,以及胎儿肝脏对这些镇痛药及其代谢物的反应的信息。从长期来看,这些数据将有助于设计孕妇使用的止痛剂,而不会对发育中的胎儿造成严重风险。
英文摘要
The use of prescription medicines is widespread with 64% of USA women prescribed one or more drugs (excluding vitamins/minerals) during pregnancy. Furthermore, use of over-the-counter medicines is very widespread especially for analgesic use (eg paracetamol, ibuprofen). The use (including dose and frequency) of these drugs is difficult to regulate and there are associations between use of analgesics during pregnancy and increased risk of congenital defects in offspring. An example is the increased cryptorchidism and reduced masculinisation of new-born boy infants if they were exposed in-utero (in the womb) to paracetamol. During pregnancy pharmacokinetics of drugs are widely known to be altered compared to non-pregnant women and what is known about fetal human metabolism, biotransformation and clearance of drugs is very limited. Therefore, inappropriate exposure to medicines during pregnancy can have serious adverse effects on the health and wellbeing of the offspring throughout life, a model that is well understood with maternal cigarette smoking or heavy alcohol consumption for instance.While the fetal human liver has been shown by us and others to be active in the late first/second trimester very little is known about the cellular mechanisms involved in uptake, metabolism/biotransformation and clearance of medicines and their metabolites. The aim of this PhD, therefore, is to define the hepatic (liver) mechanisms that mediate, or protect from, the potential risks posed by exposure to analgesics like paracetamol, and their metabolites in the human fetus.In order to achieve this aim, the student will be part of the SAFeR study (Scottish Advanced Fetal Research study) coordinated by Fowler. This study involves the collection and study of electively terminated normal human fetuses (between 7 and 20 weeks of gestation) at the Universities of Aberdeen & Glasgow (ethical approval: REC:15/NS/0123). In addition, we (Mitchell) have already measured high levels of paracetamol in the plasma of some of these SAFeR study fetuses, clearly demonstrating that this medication gets into the fetus from the mother. OBJECTIVE 1: The student will perform data-mining on Next Generation sequencing (RNA-seq) and proteomic data from 80 fetal livers already obtained as part of an MRC grant to Fowler. This will reveal human fetal hepatic gene and protein pathways involved in the metabolism and clearance of medications such as paracetamol and whether there are differences according to fetal sex.OBJECTIVE 2: In Edinburgh the student will utilise Hay's in-vitro liver systems to probe the effects of analgesics and their metabolites on hepatic function to understand the intracellular mechanisms involved in the metabolic processing of analgesics and their metabolites comparing adult with fetal.OBJECTIVE 3: The student will utilise the data from the first two objectives to study livers from fetuses with high and low paracetamol levels in order to determine which hepatic mechanisms offer protective and risk-increasing outcomes for the fetus.The intended impact of this PhD is to provide the basic mechanistic understanding of the effects of common over-the-counter analgesics on the human fetal liver, as well as information on the responses of the fetal liver to those analgesics and their metabolites. In the longer-term such data would be useful in designing analgesics that could be used by pregnant women without posing serious risks to the developing fetus.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Maternal Smoking during Pregnancy and Changes in Prostaglandin Enzymes in the Human Fetus.
母亲在怀孕期间吸烟和人类胎儿前列腺素酶的变化。
DOI: --
发表时间: 2019
期刊: REPRODUCTIVE SCIENCES
影响因子: 2.9
作者: [Zafeiri Aikaterini]
通讯作者: Zafeiri Aikaterini
Over-the-counter Analgesics in Pregnancy and Offspring Neonatal Outcomes: A Retrospective Cohort Study
非处方镇痛药对妊娠和后代新生儿结局的影响:一项回顾性队列研究
DOI: 10.1101/2020.09.24.20200188
发表时间: 2020
期刊:
影响因子: --
作者: [Zafeiri A]
通讯作者: Zafeiri A
国内基金
海外基金
面向柔性 3D 集成的仿生结构 VIA 强化方法及其机理研究
  • 批准号:
    ZCLQN26F0101
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    黄淳
  • 依托单位:
外电场调控二维VIA族单层的Rashba自旋劈裂和翘曲效应的理论研究
  • 批准号:
    12364017
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    31.00万元
  • 批准年份:
    2023
  • 负责人:
    陈少波
  • 依托单位:
二维层状VIA族材料的形成机制、生长及物性调控的第一性原理研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    55万元
  • 批准年份:
    2022
  • 负责人:
    朱志立
  • 依托单位:
蓝光IIB-VIA族半导体量子点在电致发光过程中的稳定性衰退机制及其改进策略的理论研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    60万元
  • 批准年份:
    2021
  • 负责人:
    杨明理
  • 依托单位: